XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited) - USD ($)
Cumulative Effect, Period of Adoption, Adjustment [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Noncontrolling Interest [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Class B Preferred Units [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Class B Preferred Units [Member]
Total
Balance (in shares) at Dec. 31, 2020                 0   16,115,353          
Balance at Dec. 31, 2020                 $ 0 $ 40,000,000 $ 0 $ 194,950,000 $ (117,666,000) $ (774,000) $ 99,350,000 $ 76,510,000
Accretion of discount associated with issuance of subsidiary equity                 0 0 0 (75,000) 0 0 75,000 (75,000)
Preferred dividends                 $ 0 0 $ 0 (4,612,000) 0 0 0 (4,612,000)
Stock option exercises and proceeds related thereto (in shares)                 0   494,900          
Stock option exercises and proceeds related thereto                 $ 0 0 $ 0 1,696,000 0 0 0 1,696,000
Compensatory stock issuances, net of forfeitures (in shares)                 0   39,942          
Compensatory stock issuances, net of forfeitures                 $ 0 0 $ 0 0 0 0 0 0
Deferred stock-based compensation costs                 $ 0 0 $ 0 545,000 0 0 0 $ 545,000
Redemption and retirement of shares (in shares)                 0   (9,928)         (9,928)
Redemption and retirement of shares                 $ 0 0 $ 0 (297,000) 0 0 0 $ (297,000)
Net income                 $ 0 0 $ 0 0 44,075,000 (48,000) 0 44,027,000
Balance (in shares) at Mar. 31, 2021                 0   16,640,267          
Balance at Mar. 31, 2021                 $ 0 40,000,000 $ 0 192,207,000 (73,591,000) (822,000) 99,425,000 117,794,000
Balance (in shares) at Dec. 31, 2021                 3,188,533   14,804,408          
Balance at Dec. 31, 2021 $ 0 $ 0 $ 0 $ 0 $ 8,582,000 $ 0 $ 0 $ 8,582,000 $ 0 40,000,000 $ 0 227,763,000 60,236,000 (500,000) 99,650,000 287,499,000
Accretion of discount associated with issuance of subsidiary equity                 0 0 0 (75,000) 0 0 75,000 (75,000)
Preferred dividends                 $ 0 0 $ 0 (6,131,000) 0 0 0 $ (6,131,000)
Stock option exercises and proceeds related thereto (in shares)                 0   1,000,534         1,000,534
Stock option exercises and proceeds related thereto                 $ 0 0 $ 0 2,788,000 0 0 0 $ 2,788,000
Compensatory stock issuances, net of forfeitures (in shares)                 0   113,165          
Compensatory stock issuances, net of forfeitures                 $ 0 0 $ 0 0 0 0 0 0
Contributions by owners of noncontrolling interests                 0 0 0 0 0 4,000 0 4,000
Deferred stock-based compensation costs                 $ 0 0 $ 0 1,111,000 0 0 0 $ 1,111,000
Redemption and retirement of shares (in shares)                 0   (1,005,212)         (1,005,212)
Redemption and retirement of shares                 $ 0 0 $ 0 (65,214,000) 0 0 0 $ (65,214,000)
Net income                 $ 0 0 $ 0 0 45,010,000 (255,000) 0 44,755,000
Balance (in shares) at Mar. 31, 2022                 3,188,533   14,912,895          
Balance at Mar. 31, 2022                 $ 0 $ 40,000,000 $ 0 $ 160,242,000 $ 113,828,000 $ (751,000) $ 99,725,000 $ 273,319,000